Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma

Acta Oncologica

Volumn 54, Issue 1, 2015, Pages 25-33

  Berner, Kjetil ^a,b   Johannesen, Tom Borge ^b   Berner, Aasmund ^a,c   Haugland, Hans Kristian ^d   Bjerkehagen, Bodil ^a   Bohler, Per J ^a   Bruland, Oyvind S ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CHILD; FEMALE; FEMUR OSTEOSARCOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NORWAY; OSTEOSARCOMA; OVERALL SURVIVAL; SEX RATIO; TELANGIECTASIA; TIBIA OSTEOSARCOMA; TREND STUDY; AGE DISTRIBUTION; AGED; BONE NEOPLASMS; CANCER GRADING; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TIME FACTOR; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; NORWAY; OSTEOSARCOMA; PROGNOSIS; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84919663277     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.923934     Document Type: Article

References (25)

1. KK, Inwards CY. D ahlin bone tumors, 6th ed. Philadelphia: Lippincott Williams & Wilkins;2010
2. Huvos AG. Bone tumors. Diagnosis, treatment and prognosis, 2nd ed. Philadelphia: W.B. Saunders;1991
3. Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 2009;125:229-34
4. Fletcher C DM, Bridge J. A, Hogendoorn P CW, Mertens F. WHO classification of tumours of soft tissue and bone, 4th ed. Lyon: International Agency for Research on Cancer;2013
5. Bruland O. S, Pihl A. On the current management of osteosarcoma. A critical evaluation and a proposal for a modifi ed treatment strategy. Eur J Cancer 1997;33:1725-31
6. Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG. Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery. Cancer 1979;43:2163-77
7. Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment-Where do we stand?. A state of the art review. Cancer Treat Rev 2014;40:523-32
8. C urry H, Horne G, Devane P, Tobin H. Osteosarcoma in New Zealand: An outcome study comparing survival rates between 1981-1987 and 1994-1999. N Z Med J 2006;119:U2234
9. Sampo M, Koivikko M, Taskinen M, Kallio P, Kivioja A, Tarkkanen M, et al. Incidence, epidemiology and treatment results of osteosarcoma in Finland-a nationwide population-based study. Acta Oncol 2011;50:1206-14
10. Sampo M. M, Tarkkanen M, Kivioja AH, Taskinen M. H, Sankila R, Bohling TO. Osteosarcoma in Finland from 1971 through 1990:A nationwide study of epidemiology and outcome. Acta Orthop 2008; 79:861-6
11. Whelan J, McTiernan A, Cooper N, Wong YK, Francis M, Vernon S, et al. Incidence and survival of malignant bone sarcomas in England 1979-2007. 2012;131:E508-17
12. Harvei S, Solheim O. The prognosis in osteosarcoma: Norwegian National Data. Cancer 1981;48:1719-23
13. Stiller C. A, Passmore S. J, Kroll M. E, Brownbill P. A, Wallis JC, Craft AW. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994. Br J Cancer 2006;94:22-9
14. Ferrari S, Palmerini E, Staals EL, Mercuri M, Franco B, Picci P, et al. The treatment of nonmetastatic high grade osteosarcoma of the extremity: Review of the Italian Rizzoli experience. Impact on the future. Cancer Treat Res 2009;152:275-87
15. Bielack S, Jurgens H, Jundt G, Kevric M, Kuhne T, Reichardt P, et al. Osteosarcoma: The COSS experience. Cancer Treat Res 2009;152:289-308
16. Tingulstad S, Halvorsen T, Norstein J, Hagen B, Skjeldestad FE. Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway. 2002;98:907-11
17. Sathiyamoorthy S, Ali S. Z. O steoblastic osteosarcoma: Cytomorphologic characteristics and differential diagnosis on fi ne-needle aspiration. Acta Cytol 2012;56:481-6
18. Bjerkehagen B, Wejde J, Hansson M, Domanski H, Bohling T. SSG pathology review experiences and histological grading of malignancy in sarcomas Acta Orthop 2009;80:31-6
19. Colina M, La Corte R, De Leonardis F, Trotta F
20. Bielack S, Carrle D, Casali PG. Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009;20(Suppl 4):137-9
21. Mangrud OM, Waalen R, Gudlaugsson E, Dalen I, Tasdemir I, Janssen EA, et al. Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder. PloS One 2014;9:e83192
22. Saeter G, Bruland OS, Folleras G, Boysen M, Hoie J. Extremity and non-extremity high-grade osteosarcoma-the Norwegian Radium Hospital experience during the modern chemotherapy era. Acta Oncol 1996;35(Suppl 8):129-34
23. Grimer RJ, Cannon SR, Taminiau A. M, Bielack S, Kempf-Bielack B, Windhager R, et al. Osteosarcoma over the age of forty. Eur J Cancer 2003;39:157-63
24. Bacci G, Ferrari S, Longhi A, Forni C, Zavatta M, Versari M, et al. High-grade osteosarcoma of the extremity: Differences between localized and metastatic tumors at presentation. J Pediatr Hematol Oncol 2002;24:27-30
25. Mialou V, Philip T, Kalifa C, Perol D, Gentet JC, Marec-Berard P, et al. Metastatic osteosarcoma at diagnosis: Prognostic factors and long-term outcome-the French pediatric experience. Cancer 2005;104:1100-9